{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:40:00Z","timestamp":1783107600949,"version":"3.54.6"},"reference-count":21,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"\n Background & objectives:<\/jats:title>\n Although there are reports of heterogeneous vancomycin-intermediate Staphylococcus aureus<\/jats:italic> (hVISA) across the globe, there is a lack of reliable data on hVISA in India. The present study was undertaken to determine the rate of hVISA among the methicillin-resistant Staphylococcus aureus<\/jats:italic> (MRSA) isolates, and to compare the brain heart infusion agar with vancomycin 4 \u03bcg\/ml (BHIV4) method with population analysis profile-area under the curve (PAP-AUC) method for the detection of hVISA and to study the distribution of mobile genetic element that carries methicillin-resistance gene SCCmec<\/jats:italic> (Staphylococcal cassette chromosome mec)<\/jats:italic> types among these isolates.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n BHIV4 and PAP-AUC methods were employed to detect hVISA among 500 clinical isolates of MRSA. SCCmec<\/jats:italic> typing of these isolates was performed by multiplex polymerase chain reaction. The clinical presentation, treatment with vancomycin and outcome was documented for patients with hVISA.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n The rate of hVISA was 12.4 per cent by PAP-AUC method. Sensitivity, specificity, PPV, NPV and kappa agreement of BHIV4 with PAP-AUC was 58.06, 93.15, 54.55, 94.01 per cent and 0.498, respectively. The isolation of hVISA was significantly (P<\/jats:italic><0.01) higher in patients admitted to intensive care units and wards than in patients attending the outpatient departments. Only 38 per cent of the patients received vancomycin as therapy. Majority of the hVISA isolates carried SCCmec<\/jats:italic> type V or IV.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n The rate of hVISA isolation in our study was 12.4 per cent. The sensitivity of the BHIV4 screening test was low, and was in moderate agreement with PAP-AUC test. SCCmec<\/jats:italic> type V was the predominant type seen in half of the isolates. More studies need to be done in different parts of the country on a large number of isolates to confirm our findings.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1976_17","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T05:46:12Z","timestamp":1571377572000},"page":"194-198","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus"],"prefix":"10.25259","volume":"150","author":[{"given":"Rajesh","family":"Amberpet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujatha","family":"Sistla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhan","family":"Sugumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niveditha","family":"Nagasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meerabai","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash Chandra","family":"Parija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-12-20241212","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1128\/JCM.00775-12","article-title":"Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections","volume":"50","author":"Holmes","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R2-12-20241212","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: Resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"R3-12-20241212","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/mdr.2015.0004","article-title":"Increasing trend of heterogeneous vancomycin intermediate Staphylococcus aureus in a tertiary care center of Northern India","volume":"21","author":"Singh","year":"2015","journal-title":"Microb Drug Resist"},{"key":"R4-12-20241212","doi-asserted-by":"crossref","first-page":"e0136082","DOI":"10.1371\/journal.pone.0136082","article-title":"Systematic review and meta-analysis of the epidemiology of vancomycin-intermediate and heterogeneous vancomycin-intermediate Staphylococcus aureus isolates","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"R5-12-20241212","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12879-015-1215-2","article-title":"Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care units","volume":"15","author":"Hu","year":"2015","journal-title":"BMC Infect Dis"},{"key":"R6-12-20241212","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/JCM.02302-10","article-title":"Performance of various testing methodologies for detection of heteroresistant vancomycin-intermediate Staphylococcus aureus in bloodstream isolates","volume":"49","author":"van Hal","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R7-12-20241212","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1128\/JCM.01128-10","article-title":"Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method","volume":"49","author":"Satola","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R8-12-20241212","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jgar.2016.11.006","article-title":"High frequency of SCCmec type V and agr type I among heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in North India","volume":"8","author":"Singh","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"R10-12-20241212","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/47.4.399","article-title":"A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital","volume":"47","author":"Wootton","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"R11-12-20241212","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1128\/JCM.44.3.1141-1144.2006","article-title":"Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from-resistant staphylococci","volume":"44","author":"McClure","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R12-12-20241212","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijantimicag.2013.07.010","article-title":"High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S.aureus bacteraemia patients","volume":"42","author":"Wang","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"R13-12-20241212","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1128\/JCM.43.10.5026-5033.2005","article-title":"Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus","volume":"43","author":"Zhang","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R14-12-20241212","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1128\/AAC.48.12.4926-4928.2004","article-title":"Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin","volume":"48","author":"Song","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R15-12-20241212","first-page":"176","article-title":"Modified PAP method to detect heteroresistance to vancomycin among methicillin resistant Staphylococcus aureus isolates at a tertiary care hospital","volume":"26","author":"Iyer","year":"2008","journal-title":"Indian J Med Microbiol"},{"key":"R16-12-20241212","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mjafi.2014.03.008","article-title":"Heterogeneous vancomycin-intermediate among methicillin resistant Staphylococcus aureus","volume":"71","author":"Chaudhari","year":"2015","journal-title":"Med J Armed Forces India"},{"key":"R17-12-20241212","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijantimicag.2010.06.044","article-title":"Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates","volume":"36","author":"Campanile","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"R18-12-20241212","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/381093","article-title":"Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus","volume":"38","author":"Charles","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R19-12-20241212","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/cid\/cit613","article-title":"Methicillin-resistant Staphylococcus aureus: An evolving pathogen","volume":"58","author":"Stryjewski","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R20-12-20241212","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(99)01017-X","article-title":"Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin","volume":"353","author":"Ariza","year":"1999","journal-title":"Lancet"},{"key":"R21-12-20241212","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/317542","article-title":"Vancomycin-intermediate and -resistant Staphylococcus aureus: What the infectious disease specialist needs to know","volume":"32","author":"Fridkin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R22-12-20241212","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/381202","article-title":"Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility","volume":"38","author":"Howden","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201950020-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:02:39Z","timestamp":1751497359000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/detection-of-heterogeneous-vancomycin-intermediate-staphylococcus-aureus-a-preliminary-report-from-south-india\/"}},"subtitle":["A preliminary report from south India"],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1976_17","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}